906552-18-9: Atorvastatin Pyrrolidone Analog (Free Base)

Also known as Atorvastatin lactam, it is HMG-CoA reductase inhibitors are lipid-lowering medications used in the primary and secondary prevention of coronary heart disease.

Additional information on CAS 906552-18-9

Catalogue No.

VE006732

CAS No.

906552-18-9

Molecular Formula

C33H35FN2O6

Molecular Weight

574.25

Parent drug

Atorvastatin

IUPAC Name

(3R, 5R)-7-[5-(4-Fluorophenyl)-2, 3-dihydro-3-(1-methylethyl)-2-oxo- 4-phenyl-3-[(phenylamino) carbonyl]-1H-pyrrol-1-yl]-3, 5-dihydroxy-heptanoic acid

Synonyms

Atorvastatin lactum

References

Ramkumar, Satish, et al. “Statin Therapy: Review of Safety and Potential Side Effects.” Acta Cardiologica Sinica, vol. 32, no. 6, Taiwan Society of Cardiology, 2016, pp. 631–39, https://doi.org/10.6515/ACS20160611A. McIver, Lindsey A., and Momin S. Sid ique. “Atorvastatin.” Nih.gov, StatPearls Publishing, 5 Jan. 2019, http://www.ncbi.nlm.nih.gov/books/NBK430779/.

Status

In-stock

Request a quote

906552-18-9: Atorvastatin Pyrrolidone Analog (Free Base)

906552-18-9: Atorvastatin Pyrrolidone Analog (Free Base)
Catalogue No.

VE006732

CAS No.

906552-18-9

Molecular Formula

C33H35FN2O6

Molecular Weight

574.25

Parent drug

Atorvastatin

IUPAC Name

(3R, 5R)-7-[5-(4-Fluorophenyl)-2, 3-dihydro-3-(1-methylethyl)-2-oxo- 4-phenyl-3-[(phenylamino) carbonyl]-1H-pyrrol-1-yl]-3, 5-dihydroxy-heptanoic acid

Synonyms

Atorvastatin lactum

References

Ramkumar, Satish, et al. “Statin Therapy: Review of Safety and Potential Side Effects.” Acta Cardiologica Sinica, vol. 32, no. 6, Taiwan Society of Cardiology, 2016, pp. 631–39, https://doi.org/10.6515/ACS20160611A. McIver, Lindsey A., and Momin S. Sid ique. “Atorvastatin.” Nih.gov, StatPearls Publishing, 5 Jan. 2019, http://www.ncbi.nlm.nih.gov/books/NBK430779/.

Status

In-stock

ListName

Atorvastatin Pyrrolidone Analog (Free Base)

Exclusively Supplied by Veeprho

Exclusively Supplied by Veeprho

"*" indicates required fields

Hidden
Products quotation
Name
Url